Mental illness is on the rise due to COVID-19. Could psychedelic drugs be the ‘game changer’?

Hartle was one of the first four Canadians approved by the federal government in August to use psilocybin, the active ingredient in magic mushrooms, for end-of-life anxiety treatment. He is one of the first known patients in Canada to be granted permission to use the drug for non-research purposes since it was criminalized in 1974.

Click here to read more.